
Opinion|Videos|July 3, 2024
Current and Emerging Treatment Options and Management of Duchenne Muscular Dystrophy
Author(s)Emma Ciafaloni, MD
An expert on Duchenne muscular dystrophy reviews standard-of-care treatment options and provides clinical insights on adverse effects and safety concerns, particularly with corticosteroids.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- Please briefly describe the current standard of care for Duchenne muscular dystrophy (DMD).
- What are the side effects and/or safety concerns associated with long-term use of corticosteroids in patients with DMD?
- Discuss recent approvals and ongoing studies in DMD.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Coordinating Multidisciplinary SMA Care in an Expanding Treatment Landscape
2
Tanruprubart Shows Rapid Responses in First FORWARD Cohort for Guillain-Barre Syndrome
3
Building a Multidisciplinary SMA Clinic: Lessons From 2 Decades of Practice
4
Bridging Pediatric and Adult Care in Spinal Muscular Atrophy
5











